A Computational Study to Identify Potential Inhibitors of SARS-CoV-2 Main Protease (Mpro) from Eucalyptus Active Compounds

A Computational Study to Identify Potential Inhibitors of SARS-CoV-2 Main Protease (Mpro) from Eucalyptus Active Compounds

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was found to be a severe threat to global public health in late 2019. Nevertheless, no approved medicines have been found to inhibit the virus effectively. Anti-malarial and antiviral medicines have been reported to target the SARS-CoV-2 v...

Full description

Bibliographic Details
Main Authors:	Ibrahim Ahmad Muhammad, Kanikar Muangchoo, Auwal Muhammad, Ya’u Sabo Ajingi, Ibrahim Yahaya Muhammad, Ibrahim Dauda Umar, Abubakar Bakoji Muhammad
Format:	Article
Language:	English
Published:	MDPI AG 2020-09-01
Series:	Computation
Subjects:	binding energy eucalyptus compounds molecular docking molecular dynamics SARS-CoV-2
Online Access:	https://www.mdpi.com/2079-3197/8/3/79

Similar Items

A molecular modeling study of novel aldose reductase (AR) inhibitors
by: Auwal Muhammad, et al.
Published: (2020-12-01)

In-silico investigation of phenolic compounds from leaves of Phillyrea angustifolia L. as a potential inhibitor against the SARS-CoV-2 main protease (Mpro PDB ID:5R83) using a virtual screening method
by: Abdalla, M., et al.
Published: (2022)

Essential oils as an effective alternative for the treatment of COVID-19: Molecular interaction analysis of protease (Mpro) with pharmacokinetics and toxicological properties
by: Sukanya Panikar, et al.
Published: (2021-05-01)

Virtual screenings of the bioactive constituents of tea, prickly chaff, catechu, lemon, black pepper, and synthetic compounds with the main protease (Mpro) and human angiotensin-converting enzyme 2 (ACE 2) of SARS-CoV-2
by: Nazim Uddin Emon, et al.
Published: (2021-06-01)

In silico molecular docking analysis for repurposing approved antiviral drugs against SARS-CoV-2 main protease
by: Ibrahim Khater, et al.
Published: (2021-09-01)

New Acaciin-Loaded Self-Assembled Nanofibers as MPro Inhibitors Against BCV as a Surrogate Model for SARS-CoV-2
by: Mohamad SA, et al.
Published: (2021-03-01)

COMPUTATIONAL STUDIES OF SOME BISCOUMARIN AND BISCOUMARIN THIOUREA DERIVATIVES AS ⍺-GLUCOSIDASE INHIBITORS
by: Muhammad Tukur Ibrahim, et al.
Published: (2018-07-01)

Screening of Potent Phytochemical Inhibitors Against SARS-CoV-2 Main Protease: An Integrative Computational Approach
by: Shafi Mahmud, et al.
Published: (2021-10-01)

Variações genéticas em populações de Eucalyptus spp. detectadas por meio de marcadores moleculares Genetic variations in Eucalyptus spp. genotypes detected by means of molecular markers
by: Ronaldo Pereira Caixeta, et al.
Published: (2003-06-01)

QSAR, molecular docking, and design of novel 4-(N,N-diarylmethyl amines) Furan-2(5H)-one derivatives as insecticides against Aphis craccivora
by: Yusuf Isyaku, et al.
Published: (2020-03-01)

Penambatan Molekuler dan Simulasi Dinamika Molekuler Senyawa Dari Genus Nigella Terhadap Penghambatan Aktivitas Enzim Protease HIV-1
by: Muhammad Sulaiman Zubair, et al.
Published: (2020-03-01)

In silico Analysis Revealed Potential Anti-SARS-CoV-2 Main Protease Activity by the Zonulin Inhibitor Larazotide Acetate
by: Simone Di Micco, et al.
Published: (2021-01-01)

Prediction of SARS-CoV-2 main protease inhibitors in medicinal plant-derived compounds by molecular docking approach
by: Sayma Farabi, et al.

In silico study of various antiviral drugs, vitamins, and natural substances as potential binding compounds with SARS-CoV-2 main protease
by: Michael Alabboud, et al.
Published: (2020-07-01)

Medicinal plant-based saponins targeting COVID-19 Mpro in silico
by: Mohd Rehan, et al.
Published: (2021-05-01)

Fluorogenic in vitro activity assay for the main protease Mpro from SARS-CoV-2 and its adaptation to the identification of inhibitors
by: Julien Ihssen, et al.
Published: (2021-09-01)

Teicoplanin is a potential inhibitor of SARS CoV-2 replication enzymes: A docking study
by: Aatika Sadia, et al.
Published: (2020-01-01)

Optimization Rules for SARS-CoV-2 M<sup>pro</sup> Antivirals: Ensemble Docking and Exploration of the Coronavirus Protease Active Site
by: Shana V. Stoddard, et al.
Published: (2020-08-01)

Computational Prediction of Potential Inhibitors of the Main Protease of SARS-CoV-2
by: Renata Abel, et al.
Published: (2020-12-01)

Inhibition Potencies of Phytochemicals Derived from Sesame Against SARS-CoV-2 Main Protease: A Molecular Docking and Simulation Study
by: Anuj Kumar, et al.
Published: (2021-10-01)

The actions of, and interactions between, auxins and cytokinins and their effect on in vitro rooting of selected Eucalyptus clones.
by: Nakhooda, Muhammad.
Published: (2013)

In Silico Evaluation of Iranian Medicinal Plant Phytoconstituents as Inhibitors against Main Protease and the Receptor-Binding Domain of SARS-CoV-2
by: Seyyed Sasan Mousavi, et al.
Published: (2021-09-01)

Prediction of Asiatic Acid Derivatives Affinity Against SARS-CoV-2 Main Protease Using Molecular Docking
by: Ida Musfiroh, et al.
Published: (2020-07-01)

Protease Inhibitory Effect of Natural Polyphenolic Compounds on SARS-CoV-2: An In Silico Study
by: Rajveer Singh, et al.
Published: (2020-10-01)

Support Vector Machine as a Supervised Learning for the Prioritization of Novel Potential SARS-CoV-2 Main Protease Inhibitors
by: Nedra Mekni, et al.
Published: (2021-07-01)

Drug Repurposing Approach against Novel Coronavirus Disease (COVID-19) through Virtual Screening Targeting SARS-CoV-2 Main Protease
by: Kamrul Hasan Chowdhury, et al.
Published: (2021-12-01)

Recognition of Natural Products as Potential Inhibitors of COVID-19 Main Protease (Mpro): In-Silico Evidences
by: Rohan R. Narkhede, et al.
Published: (2020-06-01)

Blue Biotechnology: Computational Screening of <i>Sarcophyton</i> Cembranoid Diterpenes for SARS-CoV-2 Main Protease Inhibition
by: Mahmoud A. A. Ibrahim, et al.
Published: (2021-07-01)

Insight into the Interaction of Cationic Porphyrin-Anthraquinone Hybrids with Hsp90: In Silico Analysis
by: Muhammad Arba, et al.
Published: (2018-12-01)

Curcumin: Synthesis optimization and in silico interaction with cyclin dependent kinase
by: Ahmed Mahmood, et al.
Published: (2017-09-01)

Plant-Based Phytochemical Screening by Targeting Main Protease of SARS-CoV-2 to Design Effective Potent Inhibitors
by: Shafi Mahmud, et al.
Published: (2021-06-01)

A New Three-Term Hestenes-Stiefel Type Method for Nonlinear Monotone Operator Equations and Image Restoration
by: Auwal Bala Abubakar, et al.
Published: (2021-01-01)

A Strategy Based on GC-MS/MS, UPLC-MS/MS and Virtual Molecular Docking for Analysis and Prediction of Bioactive Compounds in <i>Eucalyptus Globulus</i> Leaves
by: Meng Pan, et al.
Published: (2019-08-01)

In Silico Mining of Terpenes from Red-Sea Invertebrates for SARS-CoV-2 Main Protease (M<sup>pro</sup>) Inhibitors
by: Mahmoud A. A. Ibrahim, et al.
Published: (2021-04-01)

CoMFA, Molecular Docking and Molecular Dynamics Studies on Cycloguanil Analogues as Potent Antimalarial Agents
by: Isman Kurniawan, et al.
Published: (2020-09-01)

In Silico Identification of Potential Natural Product Inhibitors of Human Proteases Key to SARS-CoV-2 Infection
by: R.P. Vivek-Ananth, et al.
Published: (2020-08-01)

A Computational Approach to Explore the Interaction of Semisynthetic Nitrogenous Heterocyclic Compounds with the SARS-CoV-2 Main Protease
by: Alejandro Llanes, et al.
Published: (2021-12-01)

In silico analysis of Phyllanthus amarus phytochemicals as potent drugs against SARS-CoV-2 main protease
by: T.P. Krishna Murthy, et al.
Published: (2021-01-01)

Antiviral peptides against the main protease of SARS-CoV-2: A molecular docking and dynamics study
by: Shafi Mahmud, et al.
Published: (2021-09-01)

Identification of potential SARS-CoV-2 main protease inhibitors from Ficus Carica Latex: An in-silico approach
by: Md. Chayan Ali, et al.